News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|September 1, 2001

Should we offer HRT to ovarian and endometrial cancer survivors? No.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues

ByJoshua Fitch, Senior Editor

August 21st 2026

Rachel Meislin, MD, on when to co-manage asthma with pulmonology

ByRachel Meislin, MD

August 21st 2026

Bladder symptoms during IVF carry systemic cues that extend beyond the urinary tract

ByAleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

August 21st 2026

Rachel Meislin, MD, on structured asthma assessment and counseling in pregnancy

Rachel Meislin, MD, on structured asthma assessment and counseling in pregnancy

ByRachel Meislin, MD

August 20th 2026

20-year data show shifting causes of pregnancy-related death | image credit: stock.adobe.com

20-year data show shifting causes of pregnancy-related death

ByJoshua Fitch, Senior Editor

August 20th 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

Trending on Contemporary OB/GYN

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues

20-year data show shifting causes of pregnancy-related death

FDA-cleared, post-intercourse vaginal health device launches

Bladder symptoms during IVF carry systemic cues that extend beyond the urinary tract

Comparing GnRH Agonists and Antagonists for Endometriosis Pain